CRL Trading Analysis - 10/23/2026 03:18 PM — TRU-SENTIMENT

News Headlines & Context

Charles River Laboratories (CRL) has seen elevated attention in recent sessions amid broad contract research organization (CRO) sector rotation and a sharp late-October price surge. Relevant context based on general knowledge:

• CRL rallied sharply on October 21, 2026, closing at $346.98 after a session high of $348.63, near its 52-week high of $348.95, potentially on sector optimism or contract win speculation.
• No confirmed earnings date in embedded data, but fiscal year end was December 1, 2025 per fundamentals, suggesting upcoming annual reporting risk.
• Biopharma funding headlines have improved modestly, which can benefit CRO demand, though CRL carries negative trailing EPS of -$4.85.
• High beta (1.48) and historical volatility (44.93%) indicate the stock is prone to outsized moves on sentiment shifts.
• Options sentiment turned bearish even as price held near highs, hinting at protective positioning rather than fresh bullish conviction.

This news context is separate from the data-driven analysis below, which relies strictly on the embedded datasets.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for CRL:

• Trailing P/E is 684.90 with trailing EPS of -4.85, indicating the company is currently unprofitable on a trailing basis and valuation is extreme relative to earnings.
• Market cap is $16,510,055,760.00 with shares outstanding of 47,739,000.00 and institutional ownership at 90.41%.
• Dividend yield is 0.00% with no dividend rate or ex-dividend date supplied.
• Beta is 1.48; 52-week range is $146.20 to $348.95 (current price near top).
• Average volume is 1,037,000.00; historical volatility is 44.93%.
• Forward P/E, PEG ratio, price-to-book, total revenue, revenue growth, ROE, profit margins, debt-to-equity, and free cash flow are all null — not available in data.
• Analyst consensus, target mean price, and number of opinions are null; no street target context provided.

Fundamentally, the data shows a high-valuation, loss-making profile with strong institutional presence. This diverges from the recent sharp technical rally and contrasts with bearish options sentiment, suggesting the move may be sentiment- or momentum-driven rather than fundamentally supported.

Current Market Position

From the embedded daily and minute data:

• Daily close on 2026-10-22 was $338.74; intraday on 2026-10-23 14:50 minute bar closed at $345.84, with first 2026-10-22 09:30 bar at $340.16 and 2026-10-22 high of $351.21.
• Last 5 minute bars on 2026-10-23 show稳定 drift higher from $345.14 to $345.84 on low volume (3,887 to 7,407) after a large-volume 14:30 bar of 460,262.
• Daily 30-day range high is $351.21, low is $267.27; current price sits in upper portion of range.
• Key observational levels: Resistance near $351.21 (30d high / 2026-10-22 high); support near $337.78 (2026-10-22 low and 2026-10-23 14:30 low of $332.17 rebound).

Technical Analysis

Price is above all SMAs (5 > 20 > 50) showing bullish alignment with no bearish crossover. RSI at 70.57 is overbought, signaling momentum extreme. MACD positive with histogram 2.26 confirms bullish momentum but no divergence flagged. Bollinger upper is 333.24; current price 338.74 is above upper band, indicating expansion and potential exhaustion. Price is near top of 30-day range (high 351.21, low 267.27).

True Sentiment Analysis (Delta 40-60 Options)

From the TRUE SENTIMENT OPTIONS data:

Call Dollar Volume: $268,250.00 (32.60%) Put Dollar Volume: $555,030.00 (67.40%) Total: $823,280.00

• Sentiment is Bearish per delta 40-60 filter (6 of 400 options analyzed).
• Put dollar volume exceeds call by ~2.07x, showing directional put conviction.
• Near-term expectation from pure directional positioning: defensive or downside hedging.
• Notable divergence: technicals bullish/overbought but options flow bearish — also noted in spread recommendation as divergence.

Key Price Levels (Observational Only)